ABSTRACT Mutants of Chinese hamster ovar cells lacking dihydrofolate reductase (tetrahydrofolate dehydrogenase, 7,8-dihydrofolate:NADP+ oxidoreductase; EC 1.5.1.3) activity were isolated after mutagenesis and exposure to hi -pcificactivity [3H]deoxyuridine as a selective agent. Fully deficient mutants could not be isolated starting with wild-type cells, but could readily be selected from a putative heterozygote that contains half of the wild-type level of dihydrofolate reductase activity. The heterozygote itself was selected from wild-type cells by using [3Hjdeoxyuridine together with methotrexate to reduce intracellular dihydrofolate reductase activity. Fully deficient mutants require glycine, a purine, and thymidine for growth; this phenotype is recessive to wild type in cell hybrids. Revertants have been isolated, one of which produces a heatlabile dihydrofolate reductase activity. These mutants may be useful for metabolic studies relating to cancer chemotherapy and for fine-structure genetic mapping of mutations by using available molecular probes for this gene. (6); (fi) DHFR that is intrinsically less sensitive to MTX (6, 7); or (iii) overproduction of DHFR activity (6, 8, 9) . The last class appears to be the most common, and the overproduction has been shown to result from increased synthesis of wild-type enzyme (10, 11) due to dhfr gene amplification (12). (17) fetal calf serum whenever cell nutrition was being manipulated. Cells were grown at 370C in an atmosphere of 5% carbon dioxide.
The genetic locus (dhfr) specifying the enzyme dihydrofolate reductase (DHFR; tetrahydrofolate dehydrogenase, 7,8- dihydrofolate:NADP+ oxidoreductase; EC 1.5.1.3) is of considerable interest to mammalian cell geneticists for several reasons. This enzyme is responsible for the formation of intracellular tetrahydrofolic acid, a cofactor that is required for one-arbon transfers in various biosynthetic reactions (1, 2) . The central role of DHFR in the synthesis of nucleic acid precursors, together with its great sensitivity to tetrahydrofolate analogs such as methotrexate (MTX, amethopterin), has made this enzyme a target of wide use in cancer chemotherapy (3) . The metabolic consequences of this sensitivity have also been exploited for the nutritional manipulation of cultured mammalian cells in somatic cell genetics (e.g., hypoxanthine/amethopterin/thymidine medium; see refs. 4 
and 5).
Mutational studies of the dhfr locus have until now been confined to the phenotype of cellular resistance to the growth-inhibitory effects of MTX and related inhibitors of DHFR. MTX-resistant clones isolated from several different rodent cell lines usually exhibit one of the following three phenotypes: (i) decreased permeability to MTX (6) ; (fi) DHFR that is intrinsically less sensitive to MTX (6, 7); or (iii) overproduction of DHFR activity (6, 8, 9) . The last class appears to be the most common, and the overproduction has been shown to result from increased synthesis of wild-type enzyme (10, 11) due to dhfr gene amplification (12) .
The abundance of DHFR mRNA in MTX-resistant mouse cell mutants has made it possible to prepare purified cDNA for this gene and to clone this sequence in a bacterial host (13) . This clone represents a molecular probe that could be used to analyze mutational alterations in the chromosomal genes for DHFR. For these reasons, we undertook the development of a selective system for the isolation of mutant mammalian cells carrying lesions at the dhfr locus such that functional DHFR is no longer produced. This was accomplished in a Chinese hamster ovary (CHO) cell line with the use of [6-3H] (14) .
MATERIALS AND METHODS Culture Conditions. All cells were derivatives of the CHO-KI line (15) and were propagated in F12 medium (ref. 16 ; GIBCO) modified as indicated. The medium was supplemented with 10% (vol/vol) fetal calf serum (GIBCO) for general growth or with 10% extensively dialyzed (17) fetal calf serum whenever cell nutrition was being manipulated. Cells were grown at 370C in an atmosphere of 5% carbon dioxide.
Selection of DHFR-Deficient Mutants. Mutagenesis with ethyl methanesulfonate (EtMes) and selection of 6-thioguanine-resistant mutants have been described (18) . Mutagenesis with y rays was carried out by immersing vials containing cell suspensions in a water tank containing a cobalt-60 source for varying time intervals. The dose used for the isolation of mutants described in Table 2 was 690 rads (1 rad = 1.00 X 10-2 J/kg), which reduced viability to 9%.
A partially DHFR- (1980) 4217 DHFR Assays. Catalytic activity was measured by the procedure of Frearson et al. (19) at room temperature in a tal volume of 0.5 ml. Cell extracts were prepared by sonication (20) followed by dialysis against extraction buffer (19) .
[3H]MTX binding was measured basically as described by Johnson et al. (21) . Cytoplasmic extracts were prepared by resuspending washed cells at 2 X 108/ml in buffer A (10 mM potassium phosphate/0.15 M KCl, pH 6) containing 0.5% Nonidet P-40 (Bethesda Research, Rockville,-MD), incubating for 5 min at 00C, then centrifuging for 30 min at 12,000 X g. To 0.2 ml of the supernatant solution was added 0.1 ml of a solution containing bovine serum albumin (1 mg/ml), 0.3 mM NADPH, and 40 nM [3',5',9(n)-3H]MTX (7.5 Ci/mmol, Amersham). After (24) . Cell fusion with inactivated Sendai virus has been described (18 (18, 20) .
In two experiments, CHO-K1 cells were mutagenized with EtMes, allowed an expression period of [6] [7] (1980) Proc. Nati. Acad. Sci. USA 77 (1980) 4219 in the absence of hypoxanthine, although they still require glycine and thymidine. This phenomenon may be due, tomplification of a gene with a leaky mutation.
Although these mutants are basically stable, revertants can be isolated after further mutagenesis. In theory, revertants should be selectable in a medium lacking glycine, hypoxanthine, and thymidine, but preliminary experiments showed that omission of the purine alone was sufficient to effectively kill mutant cells and yielded revertants more consistently. Two EtMes-induced mutants (DUK22 and DUK51) were mutagenized again with EtMes, allowed a 3-day expression period in nonselective medium, and plated in F12 medium lacking hypoxanthine. Revertant colonies appeared at a frequency of 10-6. In two independent revertants of clone DUK51, DHFR activity has returned to the parental (UKB25) level (Table 2) , and these revertants are capable of growth in the absence of glycine, hypoxanthine, and thymidine. Revertants of clone DUK22, on the other hand, still require glycine and thymidine and contain a lesser amount of DHFR activity ( Table 2) .
The nature of the DHFR activity in two revertants was compared with that of wild-type cells with respect to two properties. DUK22-R1 DHFR activity was slightly but reproducibly less sensitive to MTX inhibition in cell-free extracts (ED5o = 2.5 nM, compared with 1.2 nM for CHO-Ki). A more dramatic difference was found by measuring the heat lability of enzyme activity. DUK22-R1 DHFR activity is extremely unstable at temperatures that hardly affect the wild-type enzyme, whether measured by catalytic activity (Fig. 2A) or [3H]MTX binding (Fig. 2B ). This revertant thus produces an altered enzyme, perhaps due to a second site mutation in the dhfrstructural gene that compensates for the initial lesion. The DHFR activity in the second revertant tested, DUK51-R1, was indistinguishable from wild type by these two criteria.
Cell Hybridization Experiments. To test for the dominant or recessive character of the enzyme-deficient phenotype, we fused two mutants (DUK22 and DUK51) with cells that are wild type with respect to dhfr. The latter clone (OY21) carries a dominant ouabain resistance marker and a recessive hypoxanthine phosphoribosyltransferase deficiency. After promotion of cell fusion with inactivated Sendai virus, hybrids were se- lected in medium containing 1 mM ouabain, 0.02 mM azaserine (tt inhibit de novo purine synthesis), and hypoxanthine. Hybrids derived from both mutants proved to be independent of glycine, hypoxanthine, and thymidine, indicating that the DHFR deficiencies in DUK22 and DUK51 are recessive to the wild-type allele. As part of the same experiment, DUK22 and DUK51 were fused with each other and then subjected to selection in medium lacking glycine, hypoxanthine, and thymidine. No hybrids were found among 106 parental cells subjected to fusion. Because the hybrid frequency in parallel dishes fusing the mutants to the wild-type cells was 2 X 10-4, the lack of hybrids when mutants were fused with each other can be taken as evidence for a lack of complementation between the independent mutations in these two clones. These hybridization data are what would be expected if these clones represent structural gene mutants for dhfr. (ii) they are rare in untreated populations (106) but can be induced 100-fold by the known mutagens EtMes and y rays; (iwi) they are stable, but can be induced to revert; (iv) their mutations are recessive to wild type in cell hybrids; and (v) one revertant produces an altered DHFR activity, consistent with the idea of two amino acid substitutions present in the revertant enzyme.
The fact that CHO-KI cells did not directly give rise to a mutant lacking DHFR activity suggests that there are at least two wild-type alleles for dhfr in these pseudodiploid cells. It is probable that KI cells are diplkid at this locus because, in the partially deficient, putative heterozygous derivative (UKB25), DHFR activity has been reduced by a factor of 2. Karyotypic data support this conclusion: the homogeneously staining chromosomal region that contains the amplified sequences of the dhfr gene in a MTX-resistant CHO cell mutant is located on the long arm of chromosome 2 (31) . Giemsa banding indicates that CHO cells contain both homologues of this arm (28, 31, 32) . The dhfr locus thus falls into the predominant category of diploid genes (20, 33) and is not among the class of haploid (or functionally haploid) autosomal genes found in CHO cells (34, 35) .
Completely deficient mutants could be generated starting with the partially deficient heterozygote by a second mutation in the one remaining wild-type dhfr allele. However, an alternative mechanism is the production of a homozygous negative genotype by mitotic recombination or gene conversion. Although we have shown (24) that mitotic recombination does not occur with high frequency between two X-linked markers in these cells, those negative results may not apply to all loci (36, 37) . The fact that second mutations can occur in this system is shown by the isolation of mutant clone DUK22 because it exhibits a distinctive phenotype with regard to residual enzyme activity and reversion. A more detailed survey of independent mutants will be necessary to decide whether or not second mutation is the predominant mechanism involved.
A survey of mutant genotypes has been, in fact, one of the principal objectives in the development of this selective system.
In a variety of cell lines, DHFR mRNA is overproduced due to gene amplification at this locus (reviewed in ref. 38) . In mouse cells, this has permitted the cloning in Escherichia coli of DNA sequences complementary to DHFR message. The cloned mouse sequence contains sufficient homology so as to hybridize with Chinese hamster dhfr sequences (31) . The availability of molecular probes such as this should permit fine-structure mapping by DNA sequence analysis of mutations resulting in DHFR deficiency. Such an analysis should help in determining what aspects of gene structure are necessary for gene expression and in defining the molecular consequences of spontaneous and induced mutation at the level of DNA. In addition, structural gene mutants that alter the catalytic properties of DHFR may be useful in pointing out structurefunction relationships in this small (22,000 daltons) single polypeptide enzyme (2) .
The primary metabolic effect of DHFR deficiency in these cells is a triple auxotrophy (for glycine, a purine, and thymidine). More complex aspects of folate metabolism may now be investigated by using these mutants. These include the role of DHFR in the transport of folate compounds and in the interconversion of folate metabolites and antimetabolites. Previous studies of this type often have been complicated by the interaction of these compounds with DHFR (39) .
Proteins other than DHFR that are capable of binding MTX and other folates with high affinity have been reported in some tissues (39 
